callicutt jack w top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active callicutt jack w • atlanta ga how do i update this listing callicutt jack w is based out of atlanta summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from callicutt jack w enter your email address below and choose submit your email cancel contact info callicutt jack w  fifth street nw ste  atlanta ga     business phone  sec sic codefabricated rubber products nec recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free jack callicutt  galectin therapeutics inc  zoominfocom galt jack w callicutt insider trades for galectin therapeutics inc bulletin investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close galectin therapeutics inc nasdaq galt go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus galectin therapeutics inc market open  real time quotes jul    am galt quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual jack w callicutt mr jack w callicutt cpa is cfo principal financial  accounting officer at galectin therapeutics inc mr callicutt was previously employed as chief financial officer by reach health inc chief financial officer by vystar corp chief financial officer  vice president by tikvah therapeutics inc chief financial officer  secretary by corautus genetics inc and a principal by deloitte  touche llp he received his undergraduate degree from delta state university transactions date shares transaction value     acquisition at  per share      acquisition at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr marc rubin chairman dr peter g traber president ceo chief medical officer  director dr harold h shlevin chief operating officer  secretary mr jack w callicutt chief financial  accounting officer dr eliezer zomer executive vpmanufacturing  product development mr james c czirr director mr j rex horton executive directorregulatory affairs mr john f mauldin independent director dr gilbert frank amelio independent director mr arthur r greenberg independent director mr steven prelack independent director dr gil s omenn independent director mr kevin d freeman independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest avornado realty trust stock price target cut to  from  at morgan stanley aair france’s new millennial airline may be less annoying than it sounds amicrosoft stock price target raised to  from  at ubs agold aims for a secondstraight weekly gain and highest finish in a month avisa stock price target raised to  from  at ubs aetrade stock price target raised to  from  at ubs aebay stock price target raised to  from  at ubs anic inc downgraded to neutral from buy at sidoti  co atreasury yields fall as dovish comments from ecb’s draghi fuel bond buying awhy you might want to avoid these  dividend stocks aattention shoppers ‘amazon effect’ is creating bargain stocks abreakingtrump orders report on how us defense and industry are sourced astock market pulls back from records ge disappoints alyft says it will build its own driverless car technology abull trend pauses charting the sp ’s gardenvariety pullback aoil retreats as traders await rig data opec meeting a‘property brothers’ and reality tv are inspiring homeowners — but creating unrealistic expectations about budgets atrump orders report on how us defense and industry are sourced aamazon’s foray into groceries means more mergers of food companies experts say aopinion journal california’s tesla bailout loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  jack w callicutt vp  cfo tikvah therapeutics inc a publisher of business information since         search business search executive   advanced search   sign in    hints email profiles and emails of executives   jack callicutt   vp  cfo   jack callicutts email  please login   company name  tikvah therapeutics inc   company website  httpwwwtikvahtherapeuticscom   company address   fifth st nwste  atlanta gaunited states   jack callicutts profile  vp  cfo   jack callicutts biography  jack is responsible for the company�s financial and administrative activities including interaction with capital markets and investor relations as a member of the company�s senior management and pharmaceutical leadership team he will play a key role in shaping corporate strategy importantly in his role as cfo jack will help to assure that the company has the necessary economic resources to realize its vision for its pipeline of three late stage clinical development assets which is critical to create profitable growth and shareholder valuejack has over  years of public and private company experience and more than a decade of audit tax and sec registrant experience with a major audit firm he was most recently senior vice president and chief financial and accounting officer at corautus genetics inc where he was responsible for all areas in finance accounting treasury risk management and administration for corautus which was publicly traded on nasdaq mr callicutt joined corautus in september  and during his tenure completed several private placements and convertible debt offerings totaling over  million he also negotiated and closed the recent merger of corautus with via pharmaceuticals inc prior to joining corautus genetics mr callicutt spent  years with deloitte a global accounting firm the last six years as an audit senior manager jack is a certified public accountant and graduated cum laude from delta state university jack also serves as a volunteer at the atlanta community food bank habitat for humanity and is on the advisory board of holy redeemer catholic school and a member of its finance committee   jack callicutts colleagues  name title email harold shlevin dir ceo pres please login lou barbato vp  research development chief medical officer please login garratt ponder vp  pharmaceutical development please login sandy weinberg vp  regulatory affairs quality assurance please login john graham dir please login  other executive with same profile             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory      �  walkerss research  a publisher of business information since  all rights reserved page not found  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street page not found sorry the page youre looking for is not available you might want to try our homepage our most popular stories  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers galectin therapeutics names industryveteran jack w callicutt chief financial officer galectin therapeutics names industryveteran jack w callicutt chief financial officer jun    et from galectin therapeutics norcross ga june   prnewswire  galectin therapeutics nasdaq galt the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer today announced the appointment of jack w callicutt to the position of chief financial officer effective july   mr callicutt will lead the companys financial activities including financial reporting accounting risk management public company governance interaction with capital markets and public and investor relations as a member of the senior management team mr callicutt will play a key role in shaping corporate strategy as we advance key product assets in the clinic  he will also help assure that the company has the financial resources to realize its vision for its pipeline of clinical development assets which is critical to create shareholder value jacks demonstrated leadership and dealmaking capabilities coupled with his financial management experience and industry knowledge makes him an ideal fit with the needs of the company and further consolidates our leadership group in the atlanta office i am looking forward to working closely with jack and am excited to add an individual of jacks caliber to our management team said dr peter g traber chief executive officer and chief medical officer of galectin therapeutics inc i also wish to sincerely thank mr thomas mcgauley for his years of service to the company including the last  months as acting cfo and for agreeing to work closely with jack to assure an orderly transition mr callicutt has over  years of public and private company experience including more than a decade of audit tax and sec registrant experience with a major accounting firm he was most recently cfo for reach health inc a telemedicine firm where he completed a  mm private placement previous positions include cfo of vystar corporation a public medical device company whose latex products are devoid of antigenic proteins where he led all areas of financial reporting accounting treasury risk management and administration and secured over  mm in financing previous experiences also include cfo roles at private companies including ivox and tikvah therapeutics and at coratus genetics a publicly traded biopharmaceutical company his broad background of experiences spanning a variety of technology intensive industries underpinned by a decadelong senior level role at deloitte positions him well to meaningfully contribute to the advancement of the company jack is a certified public account and graduated cum laude with a bba degree in accounting and computer science from delta state university jack is active in community affairs such as the atlanta community food bank habitat for humanity and resides with his family in alpharetta georgia   about galectin therapeutics galectin therapeutics nasdaq galt is developing promising carbohydratebased therapies for the treatment of fibrotic liver disease and cancer based on the companys unique understanding of galectin proteins key mediators of biologic function we are leveraging extensive scientific and development expertise as well as established relationships with external sources to achieve cost effective and efficient development we are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer additional information is available at wwwgalectintherapeuticscom follow us on twitter galectingalt source galectin therapeutics related links httpwwwgalectintherapeuticscom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more jul    et preview galectin therapeutics submits fast track application to fda for grmd in treatment of fatty liver disease with advanced fibrosis may    et preview galectin therapeutics to hold conference call to provide update following companys annual meeting of shareholders  new phone number for audio portion of presentation my news release contains wide tables view fullscreen looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search insider trading  callicutt jack w  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  callicutt jack w select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm na galectin therapeutics inc galt callicutt jack wchief financial officer   direct view option award  pm na galectin therapeutics inc galt callicutt jack wchief financial officer   direct view option award  pm na galectin therapeutics inc galt callicutt jack wchief financial officer   direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  jack w callicutt  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in jack w callicutt chief financial officer at galectin therapeutics inc view full profile are you jack w callicutt claim your profile   sign up for equilar atlas and view jack w callicutts full profile with equilar atlas you can identify corporate executives in jack w callicutts network and community follow changes in jack w callicutts employment and moneyinmotion connect with jack w callicutt through your network of contacts jack w callicutts executive work history current chief financial officer galectin therapeutics inc past to view jack w callicutts complete executive work history sign up now education bachelors delta state university age      jack w callicutts biography jack w callicutt age  became our chief financial officer on july   from august  through june  mr callicutt was the chief financial officer of reach health inc a telemedicine technology company headquartered in alpharetta ga from april  through august  mr callicutt was the chief financial officer of vystar corporation a publiclytraded company that holds proprietary technology to remove antigenic proteins from natural rubber latex prior to that mr callicutt was chief financial officer of ivox inc tikvah therapeutics and corautus genetics a publiclytraded biotechnology company which was developing ge  read more jack w callicutt age  became our chief financial officer on july   from august  through june  mr callicutt was the chief financial officer of reach health inc a telemedicine technology company headquartered in alpharetta ga from april  through august  mr callicutt was the chief financial officer of vystar corporation a publiclytraded company that holds proprietary technology to remove antigenic proteins from natural rubber latex prior to that mr callicutt was chief financial officer of ivox inc tikvah therapeutics and corautus genetics a publiclytraded biotechnology company which was developing gene therapy for treatment of cardiovascular disease mr callicutt previously spent more than fourteen years in public accounting most recently as a senior manager at deloitte where he specialized in technology companies from  to  mr callicutt is a certified public accountant and graduated with honors from delta state university with a bba in accounting and computer information systems source galectin therapeutics inc on    sign up for equilar atlas and view jack w callicutts full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like jack w callicutt more specifically youll be able to identify corporate executives in jack w callicutts network and community follow changes in jack w callicutts employment and moneyinmotion connect with jack w callicutt through your network of conections view full profile   search for over  executive profiles bio example jack w callicutt jack w callicutts connections  sign up now to view jack w callicutts  connections » gilbert f amelio board member galectin therapeutics inc michael k steele former vice president sales and marketing chembio diagnostics inc john r larson former board member via pharmaceuticals inc ronald l merriman board member pentair plc eric n falkenberg former board member via pharmaceuticals inc peter g traber dir president chief executive officer and chief medical officer galectin therapeutics inc b lynne parshall dir and chief operating officer ionis pharmaceuticals inc richard e otto former president chief executive officer and director via pharmaceuticals inc arthur r greenberg board member galectin therapeutics inc yawen l chiang former sr vice presidentchief scientific officer via pharmaceuticals inc popular profiles sign up now to view more executive profiles » john j kita evp and cfo a o smith elon r musk ceo and chairman tesla thomas j lynch executive chairman te connectivity ltd jan koum board member facebook inc robert d perlmutter senior evp and coo the macerich company × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   jack w callicutt cpa executive profile  biography  bloomberg july    am et biotechnology company overview of galectin therapeutics inc snapshotpeople  overviewboard memberscommittees executive profile jack w callicutt cpachief financial officer galectin therapeutics incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriesas of fiscal year  background mr jack w callicutt cpa has been the chief financial officer of galectin therapeutics inc since july   mr callicutt served as the chief financial officer of reach health inc he served as vice president of finance at reach health inc he served as the chief financial officer and vice president of tikvah therapeutics inc since august   he led the therapeuticss financial and administrative activities including interaction with capital markets  and investor relations he served as chief financial officer of vystar corporation from april   to august   and served as its principal accounting officer he served as a consultant of via pharmaceuticals inc he has over  years of public and private company experience and more than a decade of audit tax and sec registrant experience with a major audit firm he served as chief financial officer of ivox and coratus genetics he served as a chief financial officer of via pharmaceuticals inc until june   mr callicutt served as the senior vice president of corautus genetics inc since january   and also served as its chief financial officer since january  he served as the chief accounting officer and assistant secretary of corautus genetics inc since september  and served as its vice president finance and administration from september  to january   he joined corautus genetics inc in august  prior to corautus he spent  years with deloitte  touche the last six years as an audit senior manager he served on several board of nonprofit organisations he is active in community affairs such as the atlanta community food bank habitat for humanity mr callicutt is a certified public account and graduated cum laude with a bba degree in accounting and computer science from delta state university in read full background corporate headquarters  peachtree industrial boulevardnorcross georgia united statesphone fax  board members memberships there is no board members memberships data available education bba delta state university inc other affiliations corautus genetics incdelta state university incvystar corporationvia pharmaceuticals inctikvah therapeutics increach health inc annual compensation salarybonustotal annual compensation stocks options all other compensationexercisable optionsunexercisable optionstotal number of options total compensation total annual cash compensationtotal short term compensationother long term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact galectin therapeutics inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close